Ionis Pharmaceuticals Inc... (IONS)
NASDAQ: IONS
· Real-Time Price · USD
43.76
0.91 (2.12%)
At close: Aug 15, 2025, 3:59 PM
43.97
0.49%
After-hours: Aug 15, 2025, 07:55 PM EDT
Ionis Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 297.3M | 264.19M | 242.08M | 334.61M | 293.99M | 348.89M | 399.27M | 352.06M | 424.79M | 309.03M | 1.99B | 314.99M | 521.92M | 542.51M | 2.12B | 632.95M | 565.12M | 414.15M |
Short-Term Investments | 2B | 1.88B | 2.06B | 2.15B | 1.78B | 1.86B | 1.93B | 1.88B | 1.96B | 2.04B | 1.71B | 1.67B | 1.5B | 1.51B | 1.25B | 1.35B | 1.49B | 1.41B |
Long-Term Investments | 22.82M | 41.02M | 41.02M | 41.02M | 41.02M | 42.99M | 42.99M | 42.99M | 42.99M | 42.99M | 40.37M | 40.37M | 40.37M | 39.82M | 15.62M | 32.32M | 15.06M | 15.06M |
Other Long-Term Assets | 109.28M | 90.8M | 86.25M | 79.3M | 77.88M | 63.04M | 62.29M | 61.01M | 43.01M | 35.01M | 34.63M | 59.43M | 58.92M | 58.95M | 59.99M | 48.97M | 49.96M | 49.92M |
Receivables | 52.58M | 39.71M | 92.19M | 17.93M | 27.26M | 5.14M | 97.78M | 142.36M | 27.96M | 13.91M | 25.54M | 6.64M | 6.75M | 26.12M | 61.9M | 9.07M | 24M | 23.4M |
Inventory | 8.48M | 11.5M | 12.51M | 28.45M | 28.72M | 30.26M | 28.43M | 25.63M | 25.54M | 22.2M | 22.03M | 20.64M | 19.81M | 24.03M | 24.81M | 22.93M | 24.1M | 22.2M |
Other Current Assets | 223.12M | 222.57M | 217.93M | 184.19M | 194.72M | 174.06M | 184.45M | 181.07M | 177.87M | 152.34M | 157.72M | 143.17M | 142.76M | 127.11M | 125.17M | 136.64M | 131.04M | 123.83M |
Total Current Assets | 2.58B | 2.42B | 2.62B | 2.71B | 2.33B | 2.42B | 2.64B | 2.58B | 2.62B | 2.54B | 2.2B | 2.15B | 2.19B | 2.25B | 2.35B | 2.16B | 2.24B | 1.99B |
Property-Plant & Equipment | 275.88M | 262.19M | 256.11M | 246.93M | 242.84M | 242.23M | 242.94M | 245M | 269M | 264M | 256M | 180.81M | 177.01M | 177.72M | 178M | 180.14M | 179.32M | 180.41M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 29.61M | 29.05M | 29.3M | 29M | 30.04M | 29.37M | 28.8M |
Total Long-Term Assets | 407.98M | 394.02M | 383.38M | 367.25M | 361.75M | 348.25M | 348.22M | 349M | 355M | 342M | 331M | 269.85M | 264.99M | 265.97M | 267M | 259.15M | 258.65M | 259.13M |
Total Assets | 2.99B | 2.81B | 3B | 3.08B | 2.69B | 2.76B | 2.99B | 2.93B | 2.97B | 2.88B | 2.53B | 2.42B | 2.46B | 2.52B | 2.61B | 2.41B | 2.5B | 2.25B |
Account Payables | 22.8M | 17.46M | 42.96M | 9.05M | 9.24M | 13.08M | 26.03M | 5.62M | 24.02M | 10.5M | 17.92M | 20.55M | 10.35M | 16.13M | 11.9M | 8.36M | 14.66M | 9.51M |
Deferred Revenue | 75.91M | 81.1M | 78.99M | 76.02M | 94.07M | 130.41M | 151.13M | 205M | 96M | 92M | 91M | 99.51M | 93.39M | 91.44M | 98M | 97.92M | 102.07M | 106.74M |
Short-Term Debt | 643.7M | 12M | 9.28M | 44.47M | 44.42M | 44.38M | 53.16M | 9.95M | n/a | 8.24M | 7.54M | 4.97M | n/a | n/a | 3.53M | 61.94M | 69.85M | 69.5M |
Other Current Liabilities | 108.18M | 10.3M | 69.61M | 175.03M | 123.13M | 116.04M | 147.89M | 150.04M | 38.23M | 112.7M | 140.1M | 128M | 29.72M | 20.73M | 88.56M | 35.43M | 75.15M | 78.77M |
Total Current Liabilities | 897.24M | 250.29M | 309.32M | 304.57M | 306.16M | 327.65M | 448.09M | 917M | 798M | 764M | 312M | 283.45M | 267.81M | 228.45M | 241M | 279.78M | 293.82M | 295.11M |
Long-Term Debt | 1.17B | 1.41B | 1.25B | 1.23B | 1.77B | 1.76B | 1.74B | 1.79B | 1.83B | 1.18B | 1.18B | 1.23B | 1.23B | 1.23B | 1.16B | 1.22B | 1.22B | 851.82M |
Other Long-Term Liabilities | n/a | 536.14M | 542.21M | 538.1M | n/a | n/a | n/a | n/a | n/a | 778.05M | n/a | 20.9M | 22.3M | 22.3M | 67.09M | 21.63M | 18.2M | 19.1M |
Total Long-Term Liabilities | 1.46B | 2.09B | 2.11B | 2.11B | 2.12B | 2.14B | 2.16B | 1.7B | 1.75B | 1.63B | 1.65B | 1.54B | 1.56B | 1.58B | 1.6B | 1.6B | 1.62B | 1.27B |
Total Liabilities | 2.35B | 2.34B | 2.42B | 2.42B | 2.43B | 2.47B | 2.6B | 2.62B | 2.54B | 2.4B | 1.96B | 1.83B | 1.83B | 1.81B | 1.84B | 1.88B | 1.91B | 1.57B |
Total Debt | 1.97B | 1.41B | 1.42B | 1.45B | 1.98B | 1.97B | 1.45B | 1.4B | 1.47B | 1.36B | 1.34B | 1.22B | 1.22B | 1.22B | 1.16B | 1.28B | 1.28B | 909.79M |
Common Stock | 159K | 159K | 158K | 158K | 146K | 146K | 144K | 143K | 143K | 143K | 142K | 142K | 142K | 142K | 141K | 141K | 141K | 141K |
Retained Earnings | -2.27B | -2.4B | -2.25B | -2.15B | -2B | -1.94B | -1.8B | -1.79B | -1.64B | -1.55B | -1.43B | -1.38B | -1.33B | -1.23B | -1.16B | -1.38B | -1.3B | -1.22B |
Comprehensive Income | -27.99M | -28.95M | -30.81M | -24.17M | -34.84M | -34.96M | -32.65M | -46.04M | -50.91M | -48.98M | -57.48M | -63.14M | -54.01M | -48.58M | -32.67M | -27.44M | -25.8M | -24.2M |
Shareholders Equity | 631.72M | 475.73M | 588.35M | 662.47M | 263.7M | 296.51M | 386.69M | 315M | 428M | 487M | 573M | 594.36M | 624.73M | 709.57M | 772M | 530.54M | 582.67M | 680.56M |
Total Investments | 2.02B | 1.88B | 2.06B | 2.15B | 1.83B | 1.9B | 1.98B | 1.88B | 1.96B | 2.04B | 1.71B | 1.67B | 1.5B | 1.51B | 1.25B | 1.35B | 1.49B | 1.41B |